Searchable abstracts of presentations at key conferences in endocrinology

ea0038p380 | Reproduction | SFEBES2015

Self medication in transpeople is not associated with deterioration in cardiovascular risk factors but is associated with reduced vitamin D levels and antidepressant use

Seal Leighton , Khaleque Fahmin , Barrett James

Objective: This is a prospective audit looking at cardiovascular parameters in transpeople comparing those who have self medicated verses those who have not.Methods: Patients attending a workshop for new patients were questioned about cardiovascular risk factors including diabetes hypertension and smoking status. Measurements were made of lipid profile, glucose, blood pressure, waist, height and weight measurement. Those that were self medicating (SM) we...

ea0019p74 | Clinical practice/governance and case reports | SFEBES2009

Thiazolindinediones are useful in achieving female type fat distribution in male to female transsexuals

Malik I , Barrett J , Seal L

A 45-year-old male to female transsexual presented with poor female fat distribution. She had been treated with oestrogen for 13 years, initially as ethinyl oestradiol to a maximum dose of 150 ug/day, presently taking 100 mcg with GNRH analogue. On this regimen she had B cup breast development but underwent breast augmentation surgery and still suffered from low self-esteem. She was dissatisfied with her body image because she perceived a male body fat distribution. Her initia...

ea0003s11 | Recent Advances in Biological Rhythms | BES2002

Photoperiodic regulation of the neuroendocrine system

Morgan P , Ross A , Mercer J , Barrett P

For many animals anticipation of future changes in environmental conditions is a critical adaptation for survival. Seasonal changes in reproductive activity, body weight and adiposity, metabolism and coat condition are examples of such adaptive physiology. Clearly each of these involves neuroendocrine control. The environmental cue that triggers these changes is photoperiod, which is translated into the hormonal signal, melatonin, a product of the pineal gland. A considerable ...

ea0003p108 | Diabetes & Metabolism | BES2002

Paediatric diabetes survey shows type 2 diabetes prevalence 0.4%, distinct from type 1, and associated with overweight, puberty, female sex and ethnic minority status

Barrett T , Ehtisham S , Smith A , Hattersley A

Most children with diabetes are insulin deficient (type 1). We have reported type 2 diabetes in children, defined by evidence of insulin resistance, but the prevalence and characteristics in UK children is unknown. We aimed to characterise and determine the prevalence of non-type 1 diabetes in the UK. The British Society for Paediatric Endocrinology and Diabetes Clinical Trials unit undertook a cross-sectional questionnaire survey of all paediatric diabetes centres during 2000...

ea0095p121 | Gonadal, DSD and Reproduction 2 | BSPED2023

Characterising puberty in children and young people with Alstrom Syndrome

Anwunah Ijeoma , Barrett Tim , Kershaw Melanie

Background: Alstrom syndrome (AS) is a very rare multisystem disorder secondary to mutations in the ALMS1 gene, associated with infantile cardiomyopathy, retinal dystrophy, early onset obesity, and diabetes. Whilst a previous international review, including 35 males, cited pubertal delay and hypogonadism to be common, no detailed characterisation of puberty exists. This retrospective longitudinal analysis aims to describe puberty in boys with AS.<p class="...

ea0066oc8.5 | Oral Communications 8 | BSPED2019

The impact of Prader–Willi syndrome multidisciplinary clinic on growth parameters

Hu Kun , Krone Ruth , Follows Rebecca , Marks David , Barrett Timothy

Introduction: Prader–Willi Syndrome (PWS) is a rare genetic disorder due to loss of paternally inherited genes on chromosome 15q11-13. It is characterised by neonatal hypotonia, childhood hyperphagia and obesity, hypogonadism, cognitive and behavioural disabilities, and development of scoliosis. PWS multidisciplinary (MDT) clinics were introduced from 2004 at Birmingham Children’s Hospital, a tertiary paediatric centre. This enabled centralised coordination of growth...

ea0066p77 | Pituitary | BSPED2019

Observed effects of growth hormone doses on height in patients with Prader Willi Syndrome

Hu Kun , Krone Ruth , Follows Rebecca , Marks David , Barrett Timothy

Introduction: Prader–Willi Syndrome (PWS) is a rare genetic disorder due to loss of paternally inherited genes on chromosome 15q11-13. It is characterised by neonatal hypotonia, childhood obesity, hypogonadism, cognitive and behavioural disabilities, and development of scoliosis. We aimed to review the impact of growth hormone (GH) doses, scoliosis and IGF1 levels on height gain in children with PWS.Methods/design: Retrospective observational study ...

ea0039ep95 | Other | BSPED2015

Effect of dietetic management on weight in children with Bardet-Biedl syndrome

Uday Suma , Ali Muzzammil , Azam Waseema , Barrett Timothy

Introduction: Bardet-Biedl syndrome (BBS) is a monogenic disease characterized by retinitis pigmentosa (>90%), obesity (72–86%), insulin resistant diabetes, and hypogonadism. Weight management is challenging due to frequent association of learning and visual impairment. At our BBS MDT clinic, dietetic review is provided at each visit. Dietetic input focuses primarily on reduced fat and sugar content in diet and exercise is encouraged. Individualised written dietary pl...

ea0039ep113 | Pituitary and growth | BSPED2015

Endocrine outcomes in hypothalamic hamartoma: a single-centre study

Fan Hui , Shaw Nicholas , Barrett Timothy , Kirk Jeremy , Dias Renuka

Background: Hypothalamic hamartomas (HH) are congenital, benign tumours consisting of disorganised neuronal cells within the hypothalamus. They usually present with precocious puberty, seizures, behavioural abnormalities, either in isolation or combined.Aims: To look at the endocrine outcomes of patients with HH.Methods: A retrospective casenote review of all patients diagnosed with HH over a 20-year period within a single endocrin...

ea0038p247 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Is polycythaemia a marker of an increased cardiovascular risk in transmen?

Naing Aye , Lei Lily , Jones Katie , Barrett James , Seal Leighton

A retrospective single centre audit was conducted on the effects of polycythaemia in trans-male and native male.Polycythaemia is a recognised side effect of testosterone treatment. It could be viewed as a maker of excess testosterone action. We examined whether lipid profiles as a marker of cardiovascular risk differed in a population of polycythaemic transmen (TM) and native males (NM).Forty-six NM and 12 TM were identified to hav...